Financhill
Back

CRISPR Therapeutics AG Vs. Intellia Therapeutics Industry Stock Comparison

Buy
59

CRSP
CRISPR Therapeutics AG

Last Price:
56.80
Seasonality Move:
9.74%
Sell
42

NTLA
Intellia Therapeutics

Last Price:
25.95
Seasonality Move:
25.41%
Buy
59
CRISPR Therapeutics AG (CRSP) is a Buy

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

  • The current CRISPR Therapeutics AG [CRSP] share price is $54.76. The Score for CRSP is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • CRSP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Intellia Therapeutics (NTLA) is a Sell

Is Intellia Therapeutics a Buy, Sell or Hold?

  • The current Intellia Therapeutics [NTLA] share price is $25.71. The Score for NTLA is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NTLA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

  • The CRISPR Therapeutics AG share price today is $54.76
    The current trend is relatively stagnant and CRSP is experiencing slight selling pressure.

NTLA Stock Price Chart

What is Intellia Therapeutics's stock price today?

  • The Intellia Therapeutics share price today is $25.71
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NTLA is experiencing selling pressure, which indicates risk of future bearish movement.

CRSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.5 Sell
Relative Strength Index (14 RSI): 43.32 Sell
Chaikin Money Flow: -408191 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.7 - 56.38) Sell
Bollinger Bands (100): (56.6 - 75.94) Sell

NTLA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.57 Buy
Relative Strength Index (14 RSI): 58.38 Buy
Chaikin Money Flow: -630936 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.39 - 25.31) Buy
Bollinger Bands (100): (23.54 - 29.22) Sell

CRSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 55.2 Sell
20-day SMA: 54.85 Sell
50-day SMA: 61.42 Sell
200-day SMA: 59.36 Sell
8-day EMA: 55.31 Sell
20-day EMA: 55.98 Sell
50-day EMA: 60.16 Sell
200-day EMA: 61.33 Sell

NTLA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.73 Sell
20-day SMA: 23.8 Buy
50-day SMA: 24.77 Buy
200-day SMA: 29.09 Sell
8-day EMA: 25.53 Buy
20-day EMA: 24.65 Buy
50-day EMA: 24.96 Buy
200-day EMA: 29.66 Sell

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.56 per share, a decrease next quarter of $0.03 per share, a decrease this year of $2.50 per share, and an increase next year of $1.15 per share.

Intellia Therapeutics Earnings Growth & NTLA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.26 per share, and a decrease next year of $0.37 per share.

CRISPR Therapeutics AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Intellia Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):